UK alert on Lifepak 20 batteries:
This article was originally published in Clinica
Executive Summary
One of the UK's most popular automated external defibrillators (AEDs), Medtronic's Lifepak 20, is the subject of a device alert issued by the UK Medicines and Healthcare products Regulatory Agency (MHRA). Certain lots of the battery used in the device may have a short-circuiting problem that results in a reduced power capacity; some of the affected batteries have been sold separately. The lots affected are numbers 05265 and 05266, and numbers below 0539. The affected batteries were manufactured before September 2005. Medtronic recommends that batteries be replaced every two years, though service life starts at the time of supply to the end customer, the June 5 alert notes.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.